Categories Earnings, Technology

STMicroelectronics beats industry headwinds, stock jumps 6%

Shares of STMicroelectronics (NYSE: STM) shot up 6% during the pre-market hours on Thursday after the semiconductor giant reported third quarter results that were stronger than the analysts’ projections.

The company said its third quarter earnings fell to 34 cents per share, from 41 cents per share last year. However, this was 5 cents higher than the street consensus.

Despite the softness in the legacy automotive and industrial market, revenues inched up 1.2% to $2.55 billion, driven by its new products. Analysts had, on an average, expected $2.5 billion. Sales to OEMs increased 7.2%, while Distribution decreased 11.6%.

READ: PayPal jumps on upbeat Q3, becomes China’s maiden foreign payments platform

The top-line was driven by a 7.7% growth in the Analog, MEMS and Sensors Group (AMS). The company’s other two segments – Automotive and Discrete Group (ADG) and Microcontrollers and Digital ICs Group (MDG) were down year-over-year.

Outlook

For the fourth quarter, STMicroelectronics expects net income to grow 5.0% sequentially, plus or minus 350 basis points. Gross margin is expected around 38.2%, plus or minus 200 basis points.

STM stock has gained 50% since the beginning of this year.

Earlier this week, rival Texas Instruments Incorporated (NASDAQ: TXN) reported a 9% decrease in earnings for the third quarter of 2019 due to broad-based weakness in the overall demand of its product portfolio as well as macro-environment uncertainty. 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top